SLNO — SOLENO THERAPEUTICS INC

Ownership history in BRAIDWELL LP  ·  2 quarters on record

This page tracks every 13F SEC filing in which BRAIDWELL LP reported a position in SOLENO THERAPEUTICS INC (SLNO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.57% (2025 Q3)
Avg. % of fund
2.17%
First filed
2025 Q3
Last filed
2025 Q4
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 1,187,859 -94,130 -7.3% 1.76% $55.0M $46.30
2025 Q3 INITIATED 1,281,989 — — 2.57% $86.7M $67.60
% of Fund (quarterly)    SLNO price (monthly, adj. close)

Other funds also holding SLNO

As of 2025 Q4 — sorted by position size

Ally Bridge Group (NY) LLC 3Y 8.1% GREAT POINT PARTNERS LLC 3Y 7Y 6.0% Buckley Capital Advisors, LLC 4.86% Seven Fleet Capital Management LP 4.58% Commodore Capital LP 3Y 3.7% Artia Global Partners LP 3Y 3.5% Catalio Capital Management, LP 2.95% Vivo Capital, LLC 3Y 7Y 2.68% Brummer Multi-Strategy AB 2.45% KINGDON CAPITAL MANAGEMENT, L.L.C. 3Y 7Y 2.2%
← Back to BRAIDWELL LP Holdings